Clinical Research Directory
Browse clinical research sites, groups, and studies.
Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
Sponsor: University of Erlangen-Nürnberg Medical School
Summary
Analysis of the efficacy and the compatibility of deep regional hyperthermia in combination with radiotherapy and chemoradiotherapy in bladder cancer
Official title: Register-Trial Based on an Agreement of Health Insurances With the Department of Radiation Therapy of the University Hospital Erlangen for the Application of Regional Hyperthermia in Bladder Cancer: Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2017-03-29
Completion Date
2099-12-31
Last Updated
2024-05-09
Healthy Volunteers
No
Conditions
Interventions
Hyperthermia
Deep Regional Hyperthermia (RHT) 1-2/week up to 10 sessions a type of cancer treatment in which body tissue is exposed to high temperatures (up to 113°F).
Radiotherapy
50,4 Gy (28 x 1,8 Gy) plus Boost: If R0: 5,4 Gy; If R1/2: 9 Gy
Chemotherapy 5-Fluorouracil
600 mg/m\^2 civ 120h; d 1-5, 29-33
Chemotherapy Cisplatin
20 mg/m\^2; d1-5, 29-33
Locations (1)
Dept. of Radiation Therapy, University Hospital Erlangen
Erlangen, Germany